Literature DB >> 3345230

Clonal proliferation of large granular lymphocytes in rheumatoid arthritis.

T P Loughran1, G Starkebaum, P Kidd, P Neiman.   

Abstract

Some patients with chronically elevated large granular lymphocyte (LGL) numbers have rheumatoid arthritis (RA). Since these patients also may have neutropenia and splenomegaly, their symptoms resemble those of patients diagnosed as having Felty's syndrome (FS). We studied the immunophenotypic and genotypic characteristics of mononuclear cells from patients with RA and neutropenia to better determine the extent of heterogeneity in this condition. Four patients had markedly increased numbers of LGLs, which expressed HNK-1 antigen and IgG Fc receptors. In contrast, the remaining 8 patients, who had FS, had normal LGL counts, and surface marker studies showed normal numbers of HNK-1 and IgG Fc receptor positive cells. Clonal rearrangement of the T cell receptor beta chain gene was demonstrated in all 4 patients with excess LGLs, whereas a germline configuration of this gene was present in all 6 FS patients in whom this was studied. These results suggest that there are diverse groups among patients with RA and neutropenia. Since prognosis may differ, it is important to recognize that some patients who are considered to have Felty's syndrome may have a clonal proliferation of LGLs.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3345230     DOI: 10.1002/art.1780310105

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  12 in total

1.  Phenotypic and genotypic analysis of mononuclear cells from patients with Felty's syndrome.

Authors:  M J Ahern; P J Roberts-Thomson; J Bradley; C Story; P Seshadri
Journal:  Ann Rheum Dis       Date:  1990-02       Impact factor: 19.103

Review 2.  T-cell and natural killer-cell large granular lymphocyte leukemia neoplasias.

Authors:  Rebecca J Watters; Xin Liu; Thomas P Loughran
Journal:  Leuk Lymphoma       Date:  2011-07-13

Review 3.  The spectrum of large granular lymphocyte leukemia and Felty's syndrome.

Authors:  Xin Liu; Thomas P Loughran
Journal:  Curr Opin Hematol       Date:  2011-07       Impact factor: 3.284

4.  TCR1+ large granular lymphocyte proliferation in rheumatoid arthritis.

Authors:  J G Kuipers; R Jacobs; A Kemper; H Zeidler; R E Schmidt
Journal:  Rheumatol Int       Date:  1994       Impact factor: 2.631

5.  Dominant clonotypes in the repertoire of peripheral CD4+ T cells in rheumatoid arthritis.

Authors:  J J Goronzy; P Bartz-Bazzanella; W Hu; M C Jendro; D R Walser-Kuntz; C M Weyand
Journal:  J Clin Invest       Date:  1994-11       Impact factor: 14.808

6.  Coexistent Felty's syndrome and palindromic rheumatism.

Authors:  R E Alvillar; L O'Grady; D Robbins
Journal:  Ann Rheum Dis       Date:  1991-12       Impact factor: 19.103

7.  Clonality of CD3 negative large granular lymphocyte proliferations determined by PCR based X-inactivation studies.

Authors:  A Kelly; S J Richards; M Sivakumaran; C Shiach; A D Stewart; B E Roberts; C S Scott
Journal:  J Clin Pathol       Date:  1994-05       Impact factor: 3.411

8.  Characteristics of T-cell large granular lymphocyte proliferations associated with neutropenia and inflammatory arthropathy.

Authors:  Monika Prochorec-Sobieszek; Grzegorz Rymkiewicz; Hanna Makuch-Łasica; Mirosław Majewski; Katarzyna Michalak; Robert Rupiński; Krzysztof Warzocha; Renata Maryniak
Journal:  Arthritis Res Ther       Date:  2008-05-12       Impact factor: 5.156

9.  Asymptomatic T-cell large granular lymphocyte leukemia with an unusual immunophenotype.

Authors:  Panagiota K Petsa; Achilleas Karamoutsios; Lefkothea Dova; Leonidas Benetatos; Asimina Petsiou; Nikolaos Kolaitis; Antonis Georgopoulos; Georgios Vartholomatos
Journal:  Clin Pract       Date:  2012-06-27

Review 10.  Metronomic regimen as an effective treatment for aggressive T-LGL leukemia with central nervous system infiltration: clinical experience and review of literature.

Authors:  Yun Liu; Lei Fan; Huihui Zhao; Wei Xu; Jianyong Li
Journal:  Oncotarget       Date:  2017-05-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.